Five vaccines were selected by the United States in their final selection, according to the New York Times. No vaccine is currently authorized against the coronavirus.
The US administration has selected five vaccine candidates for the new coronavirus as part of its final selection, the New York Times wrote on Wednesday (June 3).
According to the daily, the finalists are Moderna, the University of Oxford associated with Astrazeneca, Johnson & Johnson, Merck and Pfizer. Among the other candidates, the French group Sanofi as well as the American biotechs Novavax Inc and Inovio Pharmaceuticals were not selected, according to the NYT.
The US administration has selected five vaccine candidates for the new coronavirus as part of its final selection, the New York Times wrote on Wednesday (June 3).
According to the daily, the finalists are Moderna, the University of Oxford associated with Astrazeneca, Johnson & Johnson, Merck and Pfizer. Among the other candidates, the French group Sanofi as well as the American biotechs Novavax Inc and Inovio Pharmaceuticals were not selected, according to the NYT.
0 Comments